ProBio and Curocell Achieve Key CAR-T Milestone with BLA Regulatory Approval and Commercial Readiness

B Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation HOPEWELL, N.J., May. 11, 2026 /PRNewswire/ — Given the accelerating global momentum in CAR-T and gene…
posteditor
posteditor
Articles: 21727

Other News